Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study.
Chu Q, Leighl NB, Surmont V, van Herpen C, Sibille A, Markman B, Clarke S, Juergens RA, Rivera MA, Andelkovic V, Rudin CM, Snow S, Kim DW, Sanatani M, Lin H, Sanghavi K, Tannenbaum-Dvir S, Basciano P, Lathers D, Urbanska K, Kollia G, He C, DiPiero A, Liu Y, Ready N. Chu Q, et al. Among authors: andelkovic v. JTO Clin Res Rep. 2022 Aug 27;3(11):100400. doi: 10.1016/j.jtocrr.2022.100400. eCollection 2022 Nov. JTO Clin Res Rep. 2022. PMID: 36275912 Free PMC article.
Traditional Foods From Maize (Zea mays L.) in Europe.
Revilla P, Alves ML, Andelković V, Balconi C, Dinis I, Mendes-Moreira P, Redaelli R, Ruiz de Galarreta JI, Vaz Patto MC, Žilić S, Malvar RA. Revilla P, et al. Among authors: andelkovic v. Front Nutr. 2022 Jan 7;8:683399. doi: 10.3389/fnut.2021.683399. eCollection 2021. Front Nutr. 2022. PMID: 35071287 Free PMC article. Review.
Targeting BRAF mutations in non-small cell lung cancer.
O'Leary CG, Andelkovic V, Ladwa R, Pavlakis N, Zhou C, Hirsch F, Richard D, O'Byrne K. O'Leary CG, et al. Among authors: andelkovic v. Transl Lung Cancer Res. 2019 Dec;8(6):1119-1124. doi: 10.21037/tlcr.2019.10.22. Transl Lung Cancer Res. 2019. PMID: 32010589 Free PMC article. Review.
11 results